Core Viewpoint - Zhiyun Health (09955) has demonstrated its strong capabilities in the medical AI sector by successfully entering a key research project focused on generative medical AI models, which is expected to enhance remote decision-making support in healthcare [1] Company Summary - Zhiyun Health's stock rose over 4%, reaching 1.55 HKD with a trading volume of 3.1421 million HKD [1] - The company has been recognized by the Hangzhou Science and Technology Bureau for its project on "Construction of Generative Medical AI Models and Key Technology Research in Remote Decision Support," highlighting its expertise in the medical AI field [1] - The generative medical AI model developed by Zhiyun Health is currently being demonstrated in multiple hospitals across the country, with plans for further expansion in coverage and application depth [1] Industry Summary - The generative medical AI model utilizes IoT perception technology and precise data routing algorithms for medical information transmission, focusing on dynamic data collection for chronic disease patients [1] - The system includes a smart diagnostic assistance system with self-optimizing parameters, enhancing the accuracy and timeliness of remote diagnoses for conditions such as diabetes, cardiovascular diseases, and chronic obstructive pulmonary disease [1] - The overall framework established by the company consists of a closed-loop medical assistance system that integrates data collection, secure transmission, and intelligent decision-making [1]